SecBot SecBot
PRESS-RELEASE ·Filed Apr 21, 2026

BNTX

BioNTech SE
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

Traders should prepare for potential volatility around the May 5 earnings release and conference call; monitor management's commentary on pipeline progress and mRNA vaccine development for non-cancer indications.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$111.60
T+0 close · Apr 21, 2026 · via day close
Latest settled
−17.96%
T+60 · $91.56
Vs SPY
−24.86%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 21 $111.60entry
  2. T+1 · 7mo ago −2.69%α −3.71% · $108.60
  3. T+5 · 7mo ago −8.55%α −9.63% · $102.06
  4. T+20 · 6mo ago −20.39%α −25.30% · $88.85
  5. T+60 · 4mo ago −17.96%α −24.86% · $91.56
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BioNTech announced it will release its first-quarter 2026 financial results on May 5, 2026, followed by a conference call and webcast to discuss the results and provide a corporate update. This is a routine earnings announcement with no financial data disclosed.

Key Facts

  • BioNTech will announce Q1 2026 financial results on May 5, 2026
  • Conference call and webcast scheduled for 8:00 a.m. ET on May 5, 2026
  • No financial results or material updates were included in this press release

Financial Impact

No financial impact from this release; actual results will be disclosed on May 5

Risk Factors

  • Earnings could miss consensus expectations given recent declines in COVID-related revenue
  • Pipeline updates may lack near-term catalysts, leading to investor skepticism

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3277750

Track record

38 reports on BNTX

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +25.10% at T+20 after the Mar 24, 2026 report. 11 of 16 went positive at some point.

Filters
  1. Nov 10, 20266d ago 6-K Neutral 4/10 Entry $87.21 Now $85.26 −2.24% settles Feb 8
  2. Nov 3, 202613d ago 6-K Neutral 5/10 No price data
  3. Nov 3, 202613d ago 6-K Neutral 5/10 No price data
  4. Nov 3, 202613d ago Press Release Neutral 5/10 Entry $86.92 Now $85.26 −1.91% settles Feb 1
  5. Oct 29, 202618d ago Institutional Cluster Mixed 3/10 Entry $89.13 Now $85.26 −4.34% settles Jan 27
  6. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $86.86 Now $85.26 −1.84% settles Jan 22
  7. Oct 26, 202621d ago 6-K Bearish 5/10 Entry $86.86 Now $85.26 +1.84% settles Jan 22
  8. Oct 26, 202621d ago Press Release Bearish 6/10 Entry $86.86 Now $85.26 +1.84% settles Jan 22
  9. Oct 25, 202622d ago Press Release Bullish 6/10 Entry $86.86 Now $85.26 −1.84% settles Jan 22
  10. Oct 22, 202625d ago 6-K Neutral 5/10 Entry $89.67 Now $85.26 −4.92% settles Jan 20
Showing 10 of 38

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026